Read + Share
Amedeo Smart
Independent Medical Education
Vande Walle L, Stowe IB, Sacha P, Lee BL, et al. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. PLoS Biol 2019;17:e3000354.PMID: 31525186
Email
LinkedIn
Facebook
Twitter
Privacy Policy